1. OAR@UM
  2. External Research Collection
  3. Medicine
  4. Medicine (General)
  5. The Synapse
  6. 2016
  7. The Synapse, Volume 15, Issue 5
Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/19042
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCassar, Andrew-
dc.date.accessioned2017-05-16T08:41:06Z-
dc.date.available2017-05-16T08:41:06Z-
dc.date.issued2016-
dc.identifier.citationCassar, A. (2016). Optimizing anticoagulant therapy in non-Valvular atrial fibrillation. The Synapse : the Medical Professionals' Network, 15(5), 11-12.en_GB
dc.identifier.urihttps://www.um.edu.mt/library/oar//handle/123456789/19042-
dc.description.abstractT he prevalence of atrial fibrillation (AF) is estimated to be around 3% of the population above 20 years of age, and increases with age, hypertension, cardiovascular disease, diabetes and obesity. Besides a 1.5- to 2-fold increase in mortality in people suffering from AF, they also have an increase in morbidity from heart failure and stroke. In fact, 20-30% of all ischaemic strokes are thought to be secondary to AF. The CHA2 DS2 -VASc score is a useful tool to quantify the yearly risk of stroke. One should note that the risk of stroke is independent of whether the AF is paroxysmal, persistent or permanent.en_GB
dc.language.isoenen_GB
dc.publisherMedical Portals Ltd.en_GB
dc.rightsinfo:eu-repo/semantics/openAccessen_GB
dc.subjectAtrial fibrillationen_GB
dc.subjectAnticoagulants (Medicine)en_GB
dc.subjectWarfarinen_GB
dc.subjectCardiology -- Researchen_GB
dc.titleOptimizing anticoagulant therapy in non-Valvular atrial fibrillationen_GB
dc.typearticleen_GB
dc.rights.holderThe copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder.en_GB
dc.description.reviewedpeer-revieweden_GB
Appears in Collections:Scholarly Works - FacM&SMed
The Synapse, Volume 15, Issue 5
The Synapse, Volume 15, Issue 5

Files in This Item:
File Description SizeFormat 
The Synapse 15-5 - A3.pdfOptimizing anticoagulant therapy in nonValvular atrial fibrillation795.04 kBAdobe PDFView/Open
Show simple item record Statistics


Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.